NCT05354466

Perioperative Respiratory Adverse events_sugammadex

Effect of Sugammadex Versus Neostigmine on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: a Randomized Controlled Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 174 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 2 Years – 6 Years
• Healthy volunteers: Not accepted

Summary

Perioperative respiratory adverse events are common in children. We aimed to evaluate the effect of sugammadex on the incidence of perioperative respiratory adverse events in pediatric patients receiving tonsillectomy

Conditions

• Respiratory Complication

Interventions

Type	Name	Description
DRUG	Sugammadex injection	sugammadex as reversal agent
DRUG	Neostigmine	neostigmine as a reversal agent

Timeline

• Start date: 2022-06-27
• Primary completion: 2024-09-04
• Completion: 2024-09-04
• First posted: 2022-04-29
• Last updated: 2024-09-20

Locations

1 site across 1 country: South Korea

Regulatory

• FDA-regulated drug study